Literature DB >> 33043385

Cardamonin inhibits cell proliferation by caspase-mediated cleavage of Raptor.

Yanting Zhu1, Jintuo Zhou1, Peiguang Niu1, Huajiao Chen1, Daohua Shi2.   

Abstract

The antiproliferative effect of cardamonin on mTORC1 is related with downregulation of Raptor. We investigated the mechanism that cardamonin decreases Raptor expression through caspase-mediated protein degradation. SKOV3 cells and HeLa cells were pretreated with caspase inhibitor z-VAD-fmk for 30 min and then exposed to different doses of cardamonin and cisplatin, respectively. We analyzed the gene expression of caspases based on TCGA and GTEx gene expression data in serous cystadenocarcinoma and normal tissues, monitored caspase activity by caspase colorimetric assay kit, detected expression of mTORC1-associated proteins and apoptosis-associated proteins by western blotting, and finally detected cell viability by methyl thiazolyl tetrazolium (MTT) assay. A different expression of caspases except caspase-1 was found between serous cystadenocarcinoma and normal tissues. Raptor was cleaved when caspases were activated by cisplatin and caspase-6/caspase-8 was activated by cardamonin in SKOV3 cells. We further used a monoclonal antibody recognizing the N-terminal part of Raptor to find that Raptor was cleaved into a smaller fragment of about 70 kDa by cardamonin and was rescued by z-VAD-fmk treatment. As a result of Raptor cleavage, mTORC1 activity was decreased and cell viability was inhibited, while cell apoptosis was induced in SKOV3 cells. Notably, similar results are only observed in HeLa cells with a high dose of cardamonin. We concluded that caspase-mediated cleavage of Raptor might be an important mechanism in that cardamonin regulated Raptor and mTORC1 activity.

Entities:  

Keywords:  Cardamonin; Caspase; Raptor; mTORC1

Year:  2020        PMID: 33043385     DOI: 10.1007/s00210-020-01986-z

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

Review 1.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

2.  Activation of specific apoptotic caspases with an engineered small-molecule-activated protease.

Authors:  Daniel C Gray; Sami Mahrus; James A Wells
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

3.  An overview on cardamonin.

Authors:  Luís Moreira Gonçalves; Inês Maria Valente; José António Rodrigues
Journal:  J Med Food       Date:  2014-01-16       Impact factor: 2.786

4.  Cardamonin attenuates chronic inflammation and tumorigenesis in colon.

Authors:  Shasha Hou; Qi Yuan; Na Yu; Bin Liu; Gai Huang; Xiaxia Yuan
Journal:  Cell Cycle       Date:  2019-10-01       Impact factor: 4.534

5.  Raptor protein contains a caspase-like domain.

Authors:  Krzysztof Ginalski; Hong Zhang; Nick V Grishin
Journal:  Trends Biochem Sci       Date:  2004-10       Impact factor: 13.807

6.  Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.

Authors:  J Chen; M Bai; C Ning; B Xie; J Zhang; H Liao; J Xiong; X Tao; D Yan; X Xi; X Chen; Y Yu; R C Bast; Z Zhang; Y Feng; W Zheng
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

7.  mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Jessie E King; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

8.  Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL.

Authors:  Androulla Elia; Ricky Henry-Grant; Charlotte Adiseshiah; Catherine Marboeuf; Rebecca J Buckley; Michael J Clemens; Satvinder Mudan; Stéphane Pyronnet
Journal:  Cell Death Dis       Date:  2017-12-12       Impact factor: 8.469

9.  PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?

Authors:  Maria Luisa Gasparri; Erlisa Bardhi; Ilary Ruscito; Andrea Papadia; Ammad Ahmad Farooqi; Claudia Marchetti; Giorgio Bogani; Irene Ceccacci; Michael D Mueller; Pierluigi Benedetti Panici
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-10-26       Impact factor: 2.915

10.  Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming.

Authors:  Jinmei Jin; Shuiping Qiu; Ping Wang; Xiaohui Liang; Fei Huang; Hui Wu; Beibei Zhang; Weidong Zhang; Xinhui Tian; Ren Xu; Hailian Shi; Xiaojun Wu
Journal:  J Exp Clin Cancer Res       Date:  2019-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.